Angela Ugwuanyi
Family · Southaven, MSNPI 1427611466
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Ipsen Bioscience Inc. at 34.2% of the total. Reporting peaked in 2024 at $6,404 and has fallen 87.5% since, to $800 in 2025. Among family clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $118.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Bioscience Inc.$4K
- Genentech USA, Inc.$2K
- Astrazeneca UK Limited$2K
- AbbVie$1K
- Janssen Scientific Affairs, LLC$428
- Lilly USA, LLC$350
- plus $3K from 15 others
Across 50 payments — averaging $130.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$4K
- Corcept Therapeutics$2K
- AbbVie$1K
What the payments were for
- Travel & lodging$6,01847%
- Food & beverage$6,74653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Bioscience Inc. | 16 | $4,362 |
| Genentech USA, Inc. | 4 | $2,049 |
| Astrazeneca UK Limited | 10 | $1,870 |
| AbbVie | 31 | $1,184 |
| Janssen Scientific Affairs, LLC | 5 | $428 |
| Lilly USA, LLC | 3 | $350 |
| Phathom Pharmaceuticals, Inc. | 3 | $338 |
| Madrigal Pharmaceuticals | 2 | $288 |
| QOL Medical, LLC | 7 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $220 |
| Johnson & Johnson | 4 | $176 |
| Corcept Therapeutics | 4 | $170 |
| Ipsen Biopharmaceuticals, Inc | 2 | $158 |
| Enterra Medical, Inc. | 1 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $143 |
| Ardelyx, Inc. | 1 | $138 |
| Intercept Pharmaceuticals, Inc. | 2 | $124 |
| Pfizer | 1 | $119 |
| Genentech, Inc. | 1 | $107 |
| Nestle Healthcare Nutrition Inc. | 5 | $96 |
| Evoke Pharma, Inc. | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,764 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 13 | $154 |
| Famotidine | 11 | $132 |
Paid to pharmacies, not to this prescriber.
Other family in Southaven
- Lindsey GarnerSouthaven$16K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.